These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4834408)

  • 1. Cytogenetic studies on the mechanism of formation of isoantigenic variants in somatic cell hybrids. I. Banding analyses of isoantigenic variant sublines derived from the fusion of TA3Ha carcinoma with MSWBS sarcoma cells.
    Wiener F; Dalianis T; Klein G; Harris H
    J Natl Cancer Inst; 1974 Jun; 52(6):1779-96. PubMed ID: 4834408
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumor-associated antigens in H-2 hemizygous isoantigenic variants of a somatic cell hybrid, derived from the fusion of a 3-methylcholanthrene-induced sarcoma and a mammary carcinoma.
    Klein G
    J Natl Cancer Inst; 1977 Feb; 58(2):383-6. PubMed ID: 833884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are methylcholanthrene-induced sarcoma-associated, rejection-inducing (TSTA) antigens, modified forms of H-2 or linked determinants?
    Klein G; Klein E
    Int J Cancer; 1975 Jun; 15(6):879-87. PubMed ID: 50291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hybrid cells derived from fusion of TA2-Ha ascites carcinoma with normal fibroblasts. II. Characterization of isoantigenic variant sublines.
    Friberg S; Klein G; Wiener F; Harris H
    J Natl Cancer Inst; 1973 May; 50(5):1269-86. PubMed ID: 4712591
    [No Abstract]   [Full Text] [Related]  

  • 5. Hybrid cells derived from fusion of TA3-Ha ascites carcinoma with normal fibroblasts. 1. Malignancy, karyotype, and formation of isoantigenic variants.
    Klein G; Friberg S; Wiener F; Harris H
    J Natl Cancer Inst; 1973 May; 50(5):1259-68. PubMed ID: 4712590
    [No Abstract]   [Full Text] [Related]  

  • 6. The stemline idiogram of the MSWBS tumor of the mouse and the problem of centric fusion.
    Levan A; Bregula U; Klein G
    Hereditas; 1972; 70(2):283-94. PubMed ID: 4680638
    [No Abstract]   [Full Text] [Related]  

  • 7. Genetic determinants of morphological differentiation in a lymphoma-sarcoma hybrid.
    Cochran AL; Harris H; Wiener F; Klein G
    J Pathol; 1975 Jan; 115(1):1-12. PubMed ID: 1151512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-associated antigens in isoantigenic variants of a 3-methylcholanthrene-induced sarcoma.
    Oth D; Berebbi M; Meyer G
    J Natl Cancer Inst; 1975 Oct; 55(4):903-8. PubMed ID: 52721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of tumorigenicity after cell hybridization in vitro.
    Spurná V; Dvorák K
    Neoplasma; 1973; 20(6):687-94. PubMed ID: 4801181
    [No Abstract]   [Full Text] [Related]  

  • 10. Expression of polyoma-induced antigens in low malignant hybrids derived from fusion of a polyoma-induced tumour with a fibroblast line.
    Meyer G; Berebbi M; Klein G
    Nature; 1974 May; 249(452):47-9. PubMed ID: 4364354
    [No Abstract]   [Full Text] [Related]  

  • 11. The analysis of malignancy by cell fusion. 3. Hybrids between diploid fibroblasts and other tumour cells.
    Harris H; Wiener F; Klein G
    J Cell Sci; 1971 May; 8(3):681-92. PubMed ID: 4325887
    [No Abstract]   [Full Text] [Related]  

  • 12. The analysis of malignancy by cell fusion. VI. Hybrids between different tumour cells.
    Wiener F; Klein G; Harris H
    J Cell Sci; 1974 Oct; 16(1):189-98. PubMed ID: 4417727
    [No Abstract]   [Full Text] [Related]  

  • 13. Tumor-host cell hybrids in radiochimeras.
    Wiener F; Fenyö EM; Klein G
    Proc Natl Acad Sci U S A; 1974 Jan; 71(1):148-52. PubMed ID: 4521047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two kinds of antigen suppression in tumor cells revealed by cell fusion.
    Klein G; Friberg S; Harris H
    J Exp Med; 1972 Apr; 135(4):839-49. PubMed ID: 5018053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of human alloantigens on man-mouse hybrids: possible syntheny between HL-A and P systems.
    Fellous M; Couillin P; Neauport-Sautes C; Frezal J; Billardon C; Dausset J
    Eur J Immunol; 1973 Sep; 3(9):543-8. PubMed ID: 4588107
    [No Abstract]   [Full Text] [Related]  

  • 16. Selection of tumor-host cell hybrids from polyoma virus- and methylcholanthrene-induced sarcomas.
    Fenyö EM; Wiener F; Klein G; Harris H
    J Natl Cancer Inst; 1973 Dec; 51(6):1865-75. PubMed ID: 4358146
    [No Abstract]   [Full Text] [Related]  

  • 17. Modes of growth and spread of a transplantable, virus-producing murine (Moloney) sarcoma: karyotypic analyses.
    Russell SW; Francke U; Buettner L; Cochrane CG
    J Natl Cancer Inst; 1974 Sep; 53(3):801-6. PubMed ID: 4414698
    [No Abstract]   [Full Text] [Related]  

  • 18. CHANGES IN THE HOST RANGE OF THE TUMOUR CELL. IMMUNOLOGICAL CHARACTERISTICS OF SPECIFIC ISOANTIGENIC VARIANTS.
    KLEIN J
    Folia Biol (Praha); 1965; 11():34-40. PubMed ID: 14281267
    [No Abstract]   [Full Text] [Related]  

  • 19. Segregation of hybrids derived from mouse lymphosarcoma cells and biochemically marked L cells.
    Spurná V; Nebola M
    Folia Biol (Praha); 1973; 19(6):424-32. PubMed ID: 4801383
    [No Abstract]   [Full Text] [Related]  

  • 20. CHANGES OF TRANSPLANTATION CHARACTERISTICS IN METHYLCHOLANTHRENE-INDUCED TUMOURS. ISOLATION OF SPECIFIC ISOANTIGENIC VARIANTS.
    KLEIN J
    Neoplasma; 1965; 12():125-30. PubMed ID: 14320330
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.